Luigi Manzione

5.1k total citations · 1 hit paper
88 papers, 3.4k citations indexed

About

Luigi Manzione is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Luigi Manzione has authored 88 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in Luigi Manzione's work include Cancer Treatment and Pharmacology (39 papers), Colorectal Cancer Treatments and Studies (24 papers) and Lung Cancer Treatments and Mutations (19 papers). Luigi Manzione is often cited by papers focused on Cancer Treatment and Pharmacology (39 papers), Colorectal Cancer Treatments and Studies (24 papers) and Lung Cancer Treatments and Mutations (19 papers). Luigi Manzione collaborates with scholars based in Italy, United States and United Kingdom. Luigi Manzione's co-authors include Ciro Gallo, Gerardo Rosati, Vittorio Gebbia, Giacomo Cartenì, Francesco Perrone, Francesco Giuliani, Evaristo Maiello, Sergio Robbiati, Stefano Cordio and Domenico Bilancia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Luigi Manzione

88 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2005 586 citations Francesco Giuliani, Luigi Manzione et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luigi Manzione Italy	29	2.4k	1.3k	637	394	386	88	3.4k
Frans Erdkamp Netherlands	26	2.7k 1.1×	1.3k 1.0×	377 0.6×	562 1.4×	572 1.5×	82	3.7k
Jean‐Pierre Lotz France	26	1.6k 0.7×	699 0.5×	698 1.1×	447 1.1×	347 0.9×	119	2.8k
Åke Berglund Sweden	26	2.0k 0.8×	530 0.4×	1.2k 1.9×	215 0.5×	276 0.7×	53	2.6k
Mahmut Gümüş Türkiye	27	2.2k 0.9×	1.2k 0.9×	757 1.2×	376 1.0×	466 1.2×	174	3.7k
Gary Richardson Australia	19	2.6k 1.1×	1.2k 1.0×	478 0.8×	429 1.1×	734 1.9×	110	3.8k
Petronella O. Witteveen Netherlands	29	2.0k 0.8×	799 0.6×	702 1.1×	436 1.1×	807 2.1×	95	3.8k
R. Delva France	21	1.3k 0.5×	1.3k 1.0×	395 0.6×	538 1.4×	657 1.7×	99	2.5k
Jean‐Paul Guastalla France	31	2.2k 0.9×	495 0.4×	521 0.8×	674 1.7×	621 1.6×	109	3.7k
Kjell M. Tveit Norway	30	1.6k 0.6×	526 0.4×	1.2k 1.8×	437 1.1×	642 1.7×	79	2.8k
Alessandra Bearz Italy	31	2.5k 1.0×	3.1k 2.4×	369 0.6×	459 1.2×	772 2.0×	176	4.4k

Countries citing papers authored by Luigi Manzione

Since Specialization

Citations

This map shows the geographic impact of Luigi Manzione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Manzione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Manzione more than expected).

Fields of papers citing papers by Luigi Manzione

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Manzione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Manzione. The network helps show where Luigi Manzione may publish in the future.

Co-authorship network of co-authors of Luigi Manzione

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Manzione. A scholar is included among the top collaborators of Luigi Manzione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Manzione. Luigi Manzione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colucci, Giuseppe, Francesco Giuliani, Carlo Garufi, et al.. (2010). Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell’Italia Meridionale Multicenter Phase II Study. Oncology. 79(5-6). 415–422. 17 indexed citations

Calabrò, Fabio, Vito Lorusso, Gerardo Rosati, et al.. (2009). Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer. 115(12). 2652–2659. 72 indexed citations

Rosati, Gerardo, et al.. (2007). Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin Plus Irinotecan in Patients with Previously Untreated Advanced Gastric Cancer. Journal of Chemotherapy. 19(5). 570–576. 4 indexed citations

Manzione, Luigi, et al.. (2007). Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience. Oncology. 73(5-6). 311–315. 24 indexed citations

Lorusso, Vito, Luigi Manzione, & Nicola Silvestris. (2007). Role of liposomal anthracyclines in breast cancer. Annals of Oncology. 18. vi70–vi73. 39 indexed citations

Mastro, Lucia Del, Francesco Perrone, Lazzaro Repetto, et al.. (2005). Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer). Annals of Oncology. 16(2). 253–258. 52 indexed citations

Rosati, Gerardo, et al.. (2005). Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients. Oncology. 69(2). 122–129. 36 indexed citations

Placido, Sabino De, Michelino De Laurentiis, M. De Lena, et al.. (2005). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. British Journal of Cancer. 92(3). 467–474. 24 indexed citations

Dinota, Angelo, et al.. (2005). Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer. Breast Cancer Research and Treatment. 89(1). 1–3. 16 indexed citations

10.

Greggi, Stefano, R.V. Iaffaioli, Antônio Rossi, et al.. (2003). An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer. Annals of Oncology. 14(9). 1406–1411. 11 indexed citations

11.

Lorusso, Domenica, Gabriella Ferrandina, Stefano Greggi, et al.. (2003). Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Annals of Oncology. 14(7). 1086–1093. 75 indexed citations

12.

Daniele, Bruno, Gerardo Rosati, Rosa Tambaro, et al.. (2003). First-Line Chemotherapy With Fluorouracil and Folinic Acid for Advanced Colorectal Cancer in Elderly Patients. Journal of Clinical Gastroenterology. 36(3). 228–233. 26 indexed citations

13.

Gridelli, Cesare, Luigi Manzione, Francesco Perrone, et al.. (2001). Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study. British Journal of Cancer. 84(1). 38–41. 14 indexed citations

14.

Santis, Stefano De, Andrea Pace, Loredana Bove, et al.. (2000). Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.. PubMed. 6(1). 90–5. 61 indexed citations

15.

Rosati, Gerardo, et al.. (2000). Rectal Neurogenic Sarcoma: Case Report and Review of the Literature. Tumori Journal. 86(1). 85–87. 3 indexed citations

16.

Caponigro, Francesco, Antonio Avallone, Alfredo Budillon, et al.. (2000). Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: A phase I–II trial of the Southern Italy Cooperative Oncology Group (SICOG). Annals of Oncology. 11(5). 575–580. 7 indexed citations

17.

Greggi, Stefano, M.G. Salerno, Giuseppe Roberto D’Agostino, et al.. (2000). Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer. Oncology. 60(1). 19–23. 31 indexed citations

18.

Frasci, G., Nicola Panza, Pasquale Comella, et al.. (1999). Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II Study. Journal of Clinical Oncology. 17(8). 2316–2316. 48 indexed citations

19.

Costanzo, Francesco Di, et al.. (1999). Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study. Breast Cancer Research and Treatment. 54(2). 165–171. 3 indexed citations

20.

Mancarella, S., Vito Lorusso, Luigi Manzione, et al.. (1999). Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trial. European Journal of Cancer. 35. S347–S348. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact